Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomeres in hematopoietic stem cells.

Gabriela M Baerlocher1, Alexander Roth, Peter M Lansdorp

  • 1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada.

Annals of the New York Academy of Sciences
|June 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same author

Academic point-of-care anti-CD19 CAR T-cell therapy induces durable remission and transient paroxysmal nocturnal hemoglobinuria-type cell expansion in a patient with multi-refractory immune thrombocytopenia.

Haematologica·2026
Same author

Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025.

International journal of cancer·2026
Same author

The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO).

International journal of cancer·2026
Same author

Sickle Cell Disease and Kidney Injury: Circulating Uromodulin Allows Early Tissue Specific Diagnosis and Monitoring of Treatment.

American journal of hematology·2026
Same author

Complete chromosome 21 centromere sequencing of families with Down syndrome.

American journal of human genetics·2026
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Hematopoietic stem cells regenerate extensively, but human telomere shortening with age may limit lymphocyte function. Telomere length may help diagnose marrow failure causes.

Area of Science:

  • Hematology
  • Cell Biology
  • Gerontology

Background:

  • Hematopoietic stem cells (HSCs) possess significant regenerative potential, demonstrated in transplantation studies.
  • Mouse HSCs show extensive self-renewal, unaffected by replicative limits.
  • Human HSCs differ, with telomere length declining notably with age in nucleated blood cells.

Purpose of the Study:

  • To investigate the role of telomere length in human hematopoietic stem cell function and age-related changes.
  • To reconcile differences in telomere biology between humans and mice.
  • To explore the utility of telomere length measurements in diagnosing marrow failure.

Main Methods:

  • Comparative analysis of telomere length dynamics in human leukocytes (lymphocytes and granulocytes) with age.

Related Experiment Videos

  • Review of existing literature on telomere biology, telomerase deficiency, and stem cell function in humans and mice.
  • Exploration of the proposed model of telomere shortening as a tumor suppressor mechanism.

    • Main Results:

    • Human leukocyte telomere length declines with age following a cubic function, more pronounced in lymphocytes than granulocytes.
    • Partial telomerase deficiency in humans leads to marrow failure, unlike in mice.
    • Telomere shortening may act as a tumor suppressor mechanism in long-lived species like humans.

    Conclusions:

    • Telomere loss in humans likely impacts lymphocyte function more than HSC function under normal aging.
    • Telomere length is critical for cell cycle progression, with a minimum repeat number required to avoid checkpoint activation.
    • Telomere length measurements can differentiate between stem cell depletion and exhaustion in marrow failure.